143 related articles for article (PubMed ID: 38247091)
21. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
Yoshino T; Arnold D; Taniguchi H; Pentheroudakis G; Yamazaki K; Xu RH; Kim TW; Ismail F; Tan IB; Yeh KH; Grothey A; Zhang S; Ahn JB; Mastura MY; Chong D; Chen LT; Kopetz S; Eguchi-Nakajima T; Ebi H; Ohtsu A; Cervantes A; Muro K; Tabernero J; Minami H; Ciardiello F; Douillard JY
Ann Oncol; 2018 Jan; 29(1):44-70. PubMed ID: 29155929
[TBL] [Abstract][Full Text] [Related]
22. [Education of oncology specialists--towards a high standard of oncology in Japan].
Nishiyama M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):1-5. PubMed ID: 20087025
[TBL] [Abstract][Full Text] [Related]
23. Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.
Takeuchi H; Saeki T; Aiba K; Tamura K; Aogi K; Eguchi K; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Wada M; Akechi T; Udagawa Y; Okawa Y; Onozawa Y; Sasaki H; Shima Y; Shimoyama N; Takeda M; Nishidate T; Yamamoto A; Ikeda T; Hirata K
Int J Clin Oncol; 2016 Feb; 21(1):1-12. PubMed ID: 26081252
[TBL] [Abstract][Full Text] [Related]
24. An introduction to the clinical practice of theranostics in oncology.
Turner JH
Br J Radiol; 2018 Nov; 91(1091):20180440. PubMed ID: 30179054
[TBL] [Abstract][Full Text] [Related]
25. Current status of medical oncology in Japan--reality gleaned from a questionnaire sent to designated cancer care hospitals.
Takiguchi Y; Sekine I; Iwasawa S; Kurimoto R; Sakaida E; Tamura K
Jpn J Clin Oncol; 2014 Jul; 44(7):632-40. PubMed ID: 24821975
[TBL] [Abstract][Full Text] [Related]
26. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Patel JD; Krilov L; Adams S; Aghajanian C; Basch E; Brose MS; Carroll WL; de Lima M; Gilbert MR; Kris MG; Marshall JL; Masters GA; O'Day SJ; Polite B; Schwartz GK; Sharma S; Thompson I; Vogelzang NJ; Roth BJ
J Clin Oncol; 2014 Jan; 32(2):129-60. PubMed ID: 24327669
[TBL] [Abstract][Full Text] [Related]
27. Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals.
Arai M; Ohno I; Takahashi K; Fan MM; Tawada A; Ishioka C; Takiguchi Y
Jpn J Clin Oncol; 2021 Nov; 51(11):1622-1627. PubMed ID: 34414432
[TBL] [Abstract][Full Text] [Related]
28. [Lessons from the 116 years (1902-2018) of history of the Japanese Society of Neurology in establishing its identity].
Kuzuhara S
Rinsho Shinkeigaku; 2020 Jan; 60(1):1-19. PubMed ID: 31852875
[TBL] [Abstract][Full Text] [Related]
29. [Tuberculosis care and new horizon of Japanese society].
Ishikawa N; Nagayama N
Kekkaku; 2012 Apr; 87(4):367-81. PubMed ID: 22702085
[TBL] [Abstract][Full Text] [Related]
30. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.
Harada M; Kimura F; Takai Y; Nakajima T; Ushijima K; Kobayashi H; Satoh T; Tozawa A; Sugimoto K; Saji S; Shimizu C; Akiyama K; Bando H; Kuwahara A; Furui T; Okada H; Kawai K; Shinohara N; Nagao K; Kitajima M; Suenobu S; Soejima T; Miyachi M; Miyoshi Y; Yoneda A; Horie A; Ishida Y; Usui N; Kanda Y; Fujii N; Endo M; Nakayama R; Hoshi M; Yonemoto T; Kiyotani C; Okita N; Baba E; Muto M; Kikuchi I; Morishige KI; Tsugawa K; Nishiyama H; Hosoi H; Tanimoto M; Kawai A; Sugiyama K; Boku N; Yonemura M; Hayashi N; Aoki D; Osuga Y; Suzuki N
Int J Clin Oncol; 2022 Feb; 27(2):265-280. PubMed ID: 34973107
[TBL] [Abstract][Full Text] [Related]
31. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
Andres MS; Pan J; Lyon AR
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
[TBL] [Abstract][Full Text] [Related]
32. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).
Popescu RA; Schäfer R; Califano R; Eckert R; Coleman R; Douillard JY; Cervantes A; Casali PG; Sessa C; Van Cutsem E; de Vries E; Pavlidis N; Fumasoli K; Wörmann B; Samonigg H; Cascinu S; Cruz Hernández JJ; Howard AJ; Ciardiello F; Stahel RA; Piccart M
Ann Oncol; 2014 Jan; 25(1):9-15. PubMed ID: 24335854
[TBL] [Abstract][Full Text] [Related]
33. Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publication.
Goto A; Ohashi K; Noda M; Noto H; Ueki K; Inoue M; Nishimura R; Takahashi S; Ioka T; Oshima M; Fujibayashi K; Tsuji A; Kodaira M; Tamakoshi A; Mimori K; Tanabe Y; Hara E; Matsuo K; Murakami Y; Watada H
Diabetol Int; 2024 Jan; 15(1):5-18. PubMed ID: 38264218
[TBL] [Abstract][Full Text] [Related]
34. Physician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology.
Ishida Y; Takahashi M; Maru M; Mori M; Henderson TO; Daugherty CK; Manabe A
Jpn J Clin Oncol; 2012 Jun; 42(6):513-21. PubMed ID: 22457322
[TBL] [Abstract][Full Text] [Related]
35. Part 1: Imaging findings of common immune checkpoint inhibitor-related adverse effects.
Noë G; Cardin A; Lasocki A
J Med Imaging Radiat Oncol; 2022 Jun; 66(4):495-501. PubMed ID: 35244329
[TBL] [Abstract][Full Text] [Related]
36. Nuclear oncology as seen by me in Japan: a historical review and future perspective.
Sasaki Y
Ann Nucl Med; 2020 Jan; 34(1):1-12. PubMed ID: 31667714
[TBL] [Abstract][Full Text] [Related]
37. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Oktay E; Levent M; Gelincik H; Aktaş G; Yumuk F; Koral L; Arpacı E; Keser M; Alkan A; Karci E; Karadurmuş N; Degirmencioglu S; Turan M; Uyeturk U; Cabuk D; Avci N; Toprak O; Ergen A; Urvay S; Bayman E; Petekkaya E; Nayir E; Paydaş S; Yavuzsen T; Senler FC; Yaren A; Barutca S; Şahinler İ; Ozyilkan O; Tanriverdi O
J Cancer Educ; 2020 Feb; 35(1):69-75. PubMed ID: 30446981
[TBL] [Abstract][Full Text] [Related]
38. Toward the realization of a better aged society: messages from gerontology and geriatrics.
Arai H; Ouchi Y; Yokode M; Ito H; Uematsu H; Eto F; Oshima S; Ota K; Saito Y; Sasaki H; Tsubota K; Fukuyama H; Honda Y; Iguchi A; Toba K; Hosoi T; Kita T;
Geriatr Gerontol Int; 2012 Jan; 12(1):16-22. PubMed ID: 22188494
[TBL] [Abstract][Full Text] [Related]
39. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
40. Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons.
Akiyama N; Okamura T; Yoshida M; Kimura SI; Yano S; Yoshida I; Kusaba H; Takahashi K; Fujita H; Fukushima K; Iwasaki H; Tamura K; Saeki T; Takamatsu Y; Zenda S
Support Care Cancer; 2022 May; 30(5):4327-4336. PubMed ID: 35094140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
